Ronald E. Pruitt - Concepedia

Author

Ronald E. Pruitt

Nashville Medical Research Institute

Also Known As

Ronald E Pruitt, Ronald E. Pruitt, Ronald Pruitt

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Nashville Medical Research Institute Center for Digestive and Liver Diseases Advanced Medical Research Institute Clinical Research Institute Wake Research

About

Ronald E. Pruitt is an author at Nashville Medical Research Institute specializing in medicine, gastroenterology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.1K
2	Gastroenterology	8	8	1.1K
3	Anesthesia	2	2	148
4	Allergy	1	1	10
5	Emergency Medicine	1	1	296

Ronald E. Pruitt

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Celecoxib for the Prevention of Sporadic Colorectal Adenomas Monica M. Bertagnolli, Craig Eagle, Ann G. Zauber, New England Journal of Medicine	2006	1K
A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy Douglas K. Rex, Raj Bhandari, Taddese Desta, Gastrointestinal Endoscopy Patient SafetyGastroenterologyPharmacotherapyCns 7056Medicine	2018	296
Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. multicenter registry Robert A. Ganz, Bergein F. Overholt, Virender K. Sharma, Gastrointestinal Endoscopy Circumferential AblationU.s. Multicenter RegistryHigh-grade DysplasiaEsophagusEsophageal Cancer	2008	237
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial Monica M. Bertagnolli, Craig Eagle, Ann G. Zauber, Cancer Prevention Research	2009	193
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: A dose-ranging study Stephen B. Hanauer, Malcolm Robinson, Ronald E. Pruitt, Gastroenterology Distal Ulcerative ColitisBudesonide EnemaGastroenterologyClinical GastroenterologySurgery	1998	177
Endoscopic Full-Thickness Plication for the Treatment of Gastroesophageal Reflux Disease: A Randomized, Sham-Controlled Trial Richard Rothstein, Charles J. Filipi, Karel Caca, Gastroenterology EndoscopyEsophagusGastroenterologyGastroesophageal Reflux DiseaseSurgery	2006	159
Computer-assisted personalized sedation for upper endoscopy and colonoscopy: a comparative, multicenter randomized study Daniel J. Pambianco, John J. Vargo, Ronald E. Pruitt, Gastrointestinal Endoscopy MedicinePatient SafetyGastroenterologyOutcomes ResearchSurgery	2010	137
A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis1 Douglas S. Levine, Dennis Riff, Ronald E. Pruitt, The American Journal of Gastroenterology	2002	130
Balsalazide Is Superior to Mesalamine in the Time to Improvement of Signs and Symptoms of Acute Mild-to-Moderate Ulcerative Colitis Ronald E. Pruitt, John S. Hanson, Michael Safdi, The American Journal of Gastroenterology	2002	120
A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohnʼs disease Robert Burakoff, Charles F. Barish, Dennis Riff, Inflammatory Bowel Diseases	2006	107

Page 1